Table 4.
Dallinga J. 2019 [80] | Bach DK. 1985 [72] |
Buist I. 2008 [73] | Lysholm J. 1987 [74] | Tauton JE. 2003 [75] | Van der Worp MP. 2016 [77] | Messier SP. 2018 [79] | Kluitenberg B. 2015 [76] | Von Rosen P. 2017 [78] | Walter SD. 1989 [81] | |
---|---|---|---|---|---|---|---|---|---|---|
Were the two groups similar and recruited from the same population? | Yes | Yes | Not applicable | Yes | Not applicable | Not applicable | Yes | Not applicable | Not applicable | Not applicable |
Were the exposures measured similarly to assign people to both exposed and unexposed groups? | Yes | Yes | Not applicable | Yes | Not applicable | Not applicable | Yes | Not applicable | Not applicable | Not applicable |
Was the exposure measured in a valid and reliable way? | Yes | Yes | Yes | Yes | Unclear | Unclear | Yes | Unclear | Unclear | Unclear |
Were confounding factors identified? | Yes | Unclear | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes |
Were strategies to deal with confounding factors stated? | Unclear | Unclear | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes |
Were the groups/participants free of the outcome at the start of the study (or at the moment of exposure)? | Unclear | Yes | Unclear | Yes | Unclear | Unclear | Yes | Yes | Unclear | Unclear |
Were the outcomes measured in a valid and reliable way? | Yes | Yes | Yes | Unclear | Yes | Yes | Yes | Yes | Yes | Yes |
Was the follow up time reported and sufficient to be long enough for outcomes to occur? | Yes | Not applicable | Unclear | Yes | Yes | Yes | Yes | Unclear | Yes | Yes |
Was follow up complete, and if not, were the reasons to loss to follow up described and explored? | Yes | Not applicable | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
Were strategies to address incomplete follow up utilized? | Yes | Not applicable | Yes | Not applicable | Unclear | No | Yes | Yes | Not applicable | Yes |
Was appropriate statistical analysis used? | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |